IL-33 in the Spotlight

Join us on Monday, May 18, 2026, in Orlando, FL or via live stream!

Program Description

Join us for this live educational symposium that brings interleukin (IL)-33, an emerging therapeutic target in respiratory medicine, to center stage. This program will examine the evolving role of IL-33 as both a driver of inflammation and a regulator of gene expression, highlighting its signaling pathways and contribution to the pathophysiology of chronic respiratory disease and acute infection. Attendees will gain insight into the scientific rationale for targeting IL-33 in therapeutic development, along with the latest updates from ongoing clinical investigations of biologic agents designed to modulate its activity. Our expert panel will share their perspectives through dynamic discussion and real-time engagement with the audience.